https://www.oursmab.com 1.0 2026-04-28 daily https://www.oursmab.com/Product/Biosimilar-Antibodies.html 0.6 2026-04-28 weekly https://www.oursmab.com/Service/Antibody-Production.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/FAQs-Products.html 0.6 2026-04-28 weekly https://www.oursmab.com/NewsSt/jkzs.html 0.6 2026-04-28 weekly https://www.oursmab.com/Contact-us.html 0.8 2026-04-28 weekly https://www.oursmab.com/Product/Conjugated-Antibodies.html 0.6 2026-04-28 weekly https://www.oursmab.com/Product/Control-Antibodies.html 0.6 2026-04-28 weekly https://www.oursmab.com/Service/Antibody-Conjugation.html 0.6 2026-04-28 weekly https://www.oursmab.com/Service/Antibody-Engineering.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/Protocol-ELISA.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/Download-Protocol.html 0.6 2026-04-28 weekly https://www.oursmab.com/NewsSt/Articles.html 0.6 2026-04-28 weekly https://www.oursmab.com/Supports.html 0.8 2026-04-28 weekly https://www.oursmab.com/News/Matrix-metalloproteinase-MMP9.html 0.5 2025-09-17 monthly https://www.oursmab.com/News/The-angiogenesis-regulator-Notch1.html 0.5 2025-08-15 monthly https://www.oursmab.com/News/Anti-Müllerian-hormone-receptor-AMHR2.html 0.5 2025-07-24 monthly https://www.oursmab.com/NewsSt/Promotion.html 0.6 2026-04-28 weekly https://www.oursmab.com/NewsSt/Company.html 0.6 2026-04-28 weekly https://www.oursmab.com/qsxxd/PrivacyPolicy.html 0.5 2026-01-14 monthly https://www.oursmab.com/Products/Atoltivimab-Biosimilar-Reference-Antibody-Zaire-Ebolavirus-Glycoprotein-RA0821-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Tocilizumab-Biosimilar-Reference-Antibody-IL6R-RA0408-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Cosfroviximab-Biosimilar-Reference-Antibody-Zaire-Ebolavirus-Glycoprotein-RA0822-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Bempikibart-Biosimilar-Reference-Antibody-IL7R-RA0409-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Maftivimab-Biosimilar-Reference-Antibody-Zaire-Ebolavirus-Glycoprotein-RA0823-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Lusvertikimab-Biosimilar-Reference-Antibody-IL7R-RA0410-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Odesivimab-Biosimilar-Reference-Antibody-Zaire-Ebolavirus-Glycoprotein-RA0824-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Porgaviximab-Biosimilar-Reference-Antibody-Zaire-Ebolavirus-Glycoprotein-RA0825-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Enokizumab-Biosimilar-Reference-Antibody-IL9-RA0411-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Bapotulimab-Biosimilar-Reference-Antibody-ILDR2-RA0412-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Benralizumab-Biosimilar-Reference-Antibody-IL5RA-RA0398-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Tarcocimab-Biosimilar-Reference-Antibody-VEGFA-RA0811-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Clazakizumab-Biosimilar-Reference-Antibody-IL6-RA0399-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Varisacumab-Biosimilar-Reference-Antibody-VEGFA-RA0812-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Olokizumab-Biosimilar-Reference-Antibody-IL6-RA0400-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Reflocibart-Biosimilar-Reference-Antibody-VEGFB-RA0813-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Siltuximab-Biosimilar-Reference-Antibody-IL6-RA0401-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Burfiralimab-Biosimilar-Reference-Antibody-VIM-RA0814-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Pritumumab-Biosimilar-Reference-Antibody-VIM-RA0815-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Products/Sirukumab-Biosimilar-Reference-Antibody-IL6-RA0402-Oursmab.html 0.5 2026-01-23 monthly https://www.oursmab.com/Resource/FAQs-Services.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/FAQs-Delivery.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/FAQs-Privacy-Policy.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/Protocol-FC.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/Protocol-IF.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/Protocol-IHC.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/Protocol-IP.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/Protocol-WB.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/Protocol-DoltBlot.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/Download-Presentations.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/Download-Posters.html 0.6 2026-04-28 weekly https://www.oursmab.com/Resource/Download-Citations.html 0.6 2026-04-28 weekly https://www.oursmab.com/News/Inducible-T-cells-costimulate-ligand-ICOSLG.html 0.5 2026-04-28 monthly https://www.oursmab.com/News/Pancreatic-cancer-therapeutic-target-PAUF.html 0.5 2026-04-27 monthly https://www.oursmab.com/News/The-calcineurin-regulatory-protein-CSP1.html 0.5 2026-04-24 monthly https://www.oursmab.com/News/Complement-core-effector-molecule-C3.html 0.5 2026-04-23 monthly https://www.oursmab.com/News/CD40-ligand-CD154.html 0.5 2026-04-22 monthly https://www.oursmab.com/News/Cytokine-receptor-like-factor-2.html 0.5 2026-04-21 monthly https://www.oursmab.com/News/ADAMTS-like-protein-5.html 0.5 2026-04-20 monthly https://www.oursmab.com/News/The-therapeutic-target-of-neuralgia-GFRA3.html 0.5 2026-04-17 monthly https://www.oursmab.com/News/Nuclear-receptor-subfamily-3-group-C-member-1.html 0.5 2026-04-16 monthly https://www.oursmab.com/News/Lectin-pathway-related-serine-protease-MASP.html 0.5 2025-09-18 monthly https://www.oursmab.com/News/Prolactin-receptor-PRLR.html 0.5 2025-09-16 monthly https://www.oursmab.com/News/The-target-of-Fibroblast-growth-factor-receptor2-FGFR2.html 0.5 2025-08-15 monthly https://www.oursmab.com/News/Vascular-endothelial-growth-factor-receptor-VEGFR2.html 0.5 2025-08-14 monthly https://www.oursmab.com/News/Apoptosis-initiating-receptor-DR5.html 0.5 2025-07-25 monthly https://www.oursmab.com/News/Development-and-preclinical-characterization-of-AMG-329-a-human-antibody-neutralizing-FLT3-ligand.html 0.5 2025-07-23 monthly https://www.oursmab.com/News/Lymphotoxin-LTA.html 0.5 2026-04-15 monthly https://www.oursmab.com/News/The-chemokine-CXCL10.html 0.5 2025-09-19 monthly https://www.oursmab.com/News/C5-The-target-of-the-complement-system.html 0.5 2025-09-15 monthly https://www.oursmab.com/News/Impact-of-antibody-Fc-engineering-on-translational-pharmacology-and-safety.html 0.5 2025-08-18 monthly https://www.oursmab.com/News/The-target-of-Microtubule-Associated-Protein-Tau-MAPT.html 0.5 2025-08-13 monthly https://www.oursmab.com/News/Collagen-recognizes-the-integrin-ITGA2.html 0.5 2025-07-29 monthly https://www.oursmab.com/News/The-target-of-Domain-Containing3-LYPD3.html 0.5 2025-07-23 monthly https://www.oursmab.com/News/Ephrin-type-A-receptor-3.html 0.5 2026-04-14 monthly https://www.oursmab.com/News/The-serine-protease-HTRA1.html 0.5 2025-09-22 monthly https://www.oursmab.com/News/The-target-of-Solute-Carrier-Family-1-Member-5-SLC1A5.html 0.5 2025-09-11 monthly https://www.oursmab.com/News/The-axon-guidance-factor-SEMA4D.html 0.5 2025-08-25 monthly https://www.oursmab.com/News/The-target-of-Mucosal-addressin-cell-adhesion-molecule-1-MAdCAM1.html 0.5 2025-08-12 monthly https://www.oursmab.com/News/The-target-of-Activin-receptor-type-2B-ACVR2B.html 0.5 2025-07-30 monthly https://www.oursmab.com/News/NEK7-phosphorylation-of-EGFR-drives-the-mechanism-of-drug-resistance-in-hepatocellular-carcinoma.html 0.5 2025-07-22 monthly https://www.oursmab.com/News/Myelin-Associated-Glycoprotein-MAG.html 0.5 2026-04-14 monthly https://www.oursmab.com/News/The-melanogenic-enzyme-GPNMB.html 0.5 2025-09-23 monthly https://www.oursmab.com/News/Parkinson-s-disease-treatment-target-SNCA.html 0.5 2025-09-10 monthly https://www.oursmab.com/News/Nuclear-regulator-of-cell-fate-Notch3.html 0.5 2025-08-26 monthly https://www.oursmab.com/News/The-target-of-Leukocyte-Immunoglobulin-Like-Receptor-B2-LILRB2.html 0.5 2025-08-11 monthly https://www.oursmab.com/News/The-target-of-Transmembrane-protein-with-an-EGF-like-and-two-Follistatin-like-domains2-TMEFF2.html 0.5 2025-07-30 monthly https://www.oursmab.com/News/The-target-of-Tumor-necrosis-factor-ligand-superfamily-member14-TNFSF14.html 0.5 2025-07-21 monthly https://www.oursmab.com/News/Gastric-mucin-MUC5A.html 0.5 2026-04-13 monthly https://www.oursmab.com/News/Recombinant-IgA-shape-the-intestinal-microbiota.html 0.5 2025-09-24 monthly https://www.oursmab.com/News/The-target-of-Stabilin-1-STAB1.html 0.5 2025-09-09 monthly https://www.oursmab.com/News/The-target-of-Leptin-receptor-LEPR.html 0.5 2025-08-29 monthly https://www.oursmab.com/News/The-target-of-Chemokine-Ligand-1-CX3CL1.html 0.5 2025-08-08 monthly https://www.oursmab.com/News/Tumor-immunoregulatory-target-ITGB6.html 0.5 2025-07-31 monthly https://www.oursmab.com/News/B-cell-brake-receptor-CD22.html 0.5 2025-07-18 monthly https://www.oursmab.com/News/Tumor-microenvironment-regulatory-factor-INHBA.html 0.5 2026-04-10 monthly https://www.oursmab.com/News/Type-I-interferon-targets-IFNA1-and-IFNB.html 0.5 2025-10-09 monthly https://www.oursmab.com/News/Neurotrophic-factor-receptor-NRP1.html 0.5 2025-09-08 monthly https://www.oursmab.com/News/Deep-learning–guided-design-of-dynamic-proteins.html 0.5 2025-08-29 monthly https://www.oursmab.com/News/The-target-of-Endothelin-1-receptor-EDNRA.html 0.5 2025-08-07 monthly https://www.oursmab.com/News/The-ADC-target-antigen-TPBG.html 0.5 2025-08-01 monthly https://www.oursmab.com/News/The-target-of-T-cell-surface-protein-tactile-CD96.html 0.5 2025-07-17 monthly https://www.oursmab.com/News/Disialoganglioside-GD3.html 0.5 2026-04-09 monthly https://www.oursmab.com/News/Optimizing-the-colloidal-stability-and-viscosity-of-multi-specific-antibodies.html 0.5 2025-10-10 monthly https://www.oursmab.com/News/The-introduction-of-Surface-Plasmon-Resonance.html 0.5 2025-09-04 monthly https://www.oursmab.com/News/Protein-antibody-SPR-enabling-new-drug-development.html 0.5 2025-09-01 monthly https://www.oursmab.com/News/The-target-of-Macrophage-colony-stimulating-factor-1-CSF1.html 0.5 2025-08-06 monthly https://www.oursmab.com/News/The-introduction-of-the-Principle-Procedure-and-Applications-of-MicroScale-ThermophoresisMST.html 0.5 2025-08-04 monthly https://www.oursmab.com/News/The-target-of-Cluster-of-Differentiation80-CD80.html 0.5 2025-07-16 monthly https://www.oursmab.com/News/Immunotherapeutic-target-FCRL5.html 0.5 2026-04-08 monthly https://www.oursmab.com/News/Sour-neuronal-signalling-attenuates-macrophage-mediated-liver-injury.html 0.5 2025-10-11 monthly https://www.oursmab.com/News/The-target-of-Signal-Regulatory-Protein-Alpha-SIRPα.html 0.5 2025-09-03 monthly https://www.oursmab.com/News/The-target-of-Sialic-acid-binding-Ig-like-lectin-8-SIGLEC8.html 0.5 2025-09-02 monthly https://www.oursmab.com/News/Lysyl-oxidase-like-protein-LOXL2.html 0.5 2025-08-06 monthly https://www.oursmab.com/News/The-epidermal-growth-factor-receptor-ligand-EREG.html 0.5 2025-08-05 monthly https://www.oursmab.com/News/A-simple-practice-guide-for-dose-conversion-between-animals-and-human.html 0.5 2025-07-16 monthly https://www.oursmab.com/News/Hepatocyte-growth-factor-HGF.html 0.5 2026-04-08 monthly https://www.oursmab.com/News/The-cell-adhesion-molecule-ITGB2.html 0.5 2025-10-13 monthly https://www.oursmab.com/News/The-target-of-Insulin-receptor-INSR.html 0.5 2025-07-15 monthly https://www.oursmab.com/News/Dipeptidase-DPEP3.html 0.5 2026-04-07 monthly https://www.oursmab.com/News/Killer-cell-lectin-like-receptor-KLRG1.html 0.5 2025-10-14 monthly https://www.oursmab.com/News/Tumor-escape-switch-PD-1-PD-L1.html 0.5 2025-07-14 monthly https://www.oursmab.com/News/Contact-activated-serine-protease-F12.html 0.5 2026-03-30 monthly https://www.oursmab.com/News/The-transglutaminase-TGM2.html 0.5 2025-10-15 monthly https://www.oursmab.com/News/SAAINT-DB-a-comprehensive-structural-antibody-database-for-antibody-modeling-and-design.html 0.5 2025-07-09 monthly https://www.oursmab.com/News/Tumor-treatment-target-Ganglioside-GD2.html 0.5 2026-03-30 monthly https://www.oursmab.com/News/The-immune-regulatory-lectin-KLRB1.html 0.5 2025-10-20 monthly https://www.oursmab.com/News/The-target-of-B-cell-activating-factor-receptor-BAFFR.html 0.5 2025-07-08 monthly https://www.oursmab.com/News/Senescence-associated-metabolic-alterations-aggravate-calcific-aortic-valve-disease.html 0.5 2026-03-23 monthly https://www.oursmab.com/News/The-co-inhibitory-immune-checkpoint-KLRC1.html 0.5 2025-10-21 monthly https://www.oursmab.com/News/The-target-of-MUC17-transmembrane-mucin-MUC17.html 0.5 2025-07-07 monthly https://www.oursmab.com/News/The-zinc-transporter-SLC39A6.html 0.5 2026-03-23 monthly https://www.oursmab.com/News/The-cell-adhesion-molecule-ALCAM.html 0.5 2025-10-27 monthly https://www.oursmab.com/News/Granulocyte-colony-stimulating-factor-receptor-CSF3R.html 0.5 2025-07-02 monthly https://www.oursmab.com/News/The-Coagulation-factor-FIX.html 0.5 2026-03-23 monthly https://www.oursmab.com/News/Killer-cell-activation-receptor-KLRK1.html 0.5 2025-10-28 monthly https://www.oursmab.com/News/The-immunosuppressive-enzyme-CD39.html 0.5 2025-07-01 monthly https://www.oursmab.com/News/Complement-alternative-pathway-rate-limiting-enzyme-CFD.html 0.5 2026-03-17 monthly https://www.oursmab.com/News/The-lymphocyte-antigen-CD205.html 0.5 2025-10-29 monthly https://www.oursmab.com/News/The-therapeutic-target-of-systemic-lupus-erythematosus-BDCA2.html 0.5 2025-06-30 monthly https://www.oursmab.com/News/Vascular-endothelial-growth-factor-VEGFB.html 0.5 2026-03-16 monthly https://www.oursmab.com/News/Target-for-Alzheimer-s-disease-treatment-LGALS3.html 0.5 2025-10-30 monthly https://www.oursmab.com/News/Bone-morphogenetic-protein-antagonist-GREM1.html 0.5 2025-06-27 monthly https://www.oursmab.com/News/Sodium-dependent-phosphate-transporter-SLC34A2.html 0.5 2026-03-10 monthly https://www.oursmab.com/News/The-biligand-shared-receptor-OSMR.html 0.5 2025-11-03 monthly https://www.oursmab.com/News/The-myogenesis-inhibitory-factor-MSTN.html 0.5 2025-06-24 monthly https://www.oursmab.com/News/Sialylated-Inhibitory-Receptor-Ligand-CD52.html 0.5 2026-03-09 monthly https://www.oursmab.com/News/Epidermal-growth-factor-like-protein-EGFL7.html 0.5 2025-11-04 monthly https://www.oursmab.com/News/Lymphocyte-activation-targets-CD6.html 0.5 2025-06-23 monthly https://www.oursmab.com/News/Inflammatory-cytokine-receptor-IL1RAP.html 0.5 2026-03-09 monthly https://www.oursmab.com/News/ZBP1-can-antagonize-the-DNA-end-excision-mediated-by-MRE11.html 0.5 2025-11-04 monthly https://www.oursmab.com/News/Multifunctional-cell-adhesion-and-signaling-molecule-CEACAM6.html 0.5 2025-06-18 monthly https://www.oursmab.com/News/The-integrin-subunit-ITGA4.html 0.5 2026-03-02 monthly https://www.oursmab.com/News/Human-guanylate-cyclase-GUCY2C.html 0.5 2025-11-10 monthly https://www.oursmab.com/News/Activin-receptor-type-1-kinase-ACVR1.html 0.5 2025-06-17 monthly https://www.oursmab.com/News/The-platelet-glycoprotein-GP6.html 0.5 2026-03-02 monthly https://www.oursmab.com/News/Macrophage-stimulating-protein-receptor-MST1R.html 0.5 2025-11-10 monthly https://www.oursmab.com/News/Tyrosine-protein-kinase-transmembrane-receptor-ROR2.html 0.5 2025-06-16 monthly https://www.oursmab.com/News/STIM1-regulates-iron-homeostasis-and-promotes-neuronal-ferroptosis-to-aggravate-cerebral-hemorrhage.html 0.5 2026-03-02 monthly https://www.oursmab.com/News/The-key-regulator-of-angiogenesis-RSPO3.html 0.5 2025-11-11 monthly https://www.oursmab.com/News/The-costimulatory-receptor-GITR.html 0.5 2025-06-10 monthly https://www.oursmab.com/News/Calcium-dependent-agglutinin-APCS.html 0.5 2026-02-25 monthly https://www.oursmab.com/News/Pain-treatment-target-NGF.html 0.5 2025-11-17 monthly https://www.oursmab.com/News/Anti-fibrotic-target-CTGF.html 0.5 2025-06-09 monthly https://www.oursmab.com/News/Vascular-development-regulatory-factor-ACVRL1.html 0.5 2026-02-24 monthly https://www.oursmab.com/News/Vascular-endothelial-growth-factor-receptor-VEGFR1.html 0.5 2025-11-17 monthly https://www.oursmab.com/News/T-cell-activation-regulatory-factor-DPP4.html 0.5 2025-06-06 monthly https://www.oursmab.com/News/Von-Willebrand-factor-VWF.html 0.5 2026-02-24 monthly https://www.oursmab.com/News/Oxidized-low-density-lipoprotein-receptor-OLR1.html 0.5 2025-11-18 monthly https://www.oursmab.com/News/IL12B-is-the-core-component-of-the-immune-engine-IL12.html 0.5 2025-06-05 monthly https://www.oursmab.com/News/Tuning-Heavy-and-Light-Chain-Promoters-for-High-Throughput-CHO-Antibody-Production.html 0.5 2026-02-03 monthly https://www.oursmab.com/News/The-osteogenesis-inhibitor-SOST.html 0.5 2025-11-24 monthly https://www.oursmab.com/News/A-comprehensive-antigen-antibody-complex-database-unlocking-insights-into-interaction-interface.html 0.5 2025-06-04 monthly https://www.oursmab.com/News/Coagulation-factor-F11.html 0.5 2026-02-02 monthly https://www.oursmab.com/News/The-target-for-regulating-melanin-production-TYRP1.html 0.5 2025-11-24 monthly https://www.oursmab.com/News/DKK1-is-the-core-accomplicker-of-tumor-immune-escape.html 0.5 2025-06-02 monthly https://www.oursmab.com/News/Leukemia-inhibitory-factor-LIF.html 0.5 2026-02-02 monthly https://www.oursmab.com/News/Transmembrane-serine-threonine-kinases-TGFBR1-and-TGFBR2.html 0.5 2025-11-25 monthly https://www.oursmab.com/News/Macrophage-activation-marker-CD163.html 0.5 2025-05-27 monthly https://www.oursmab.com/News/Angiogenesis-regulatory-target-TNC.html 0.5 2026-01-27 monthly https://www.oursmab.com/News/Regulatory-target-of-neuronal-regeneration-and-survival-RGMA.html 0.5 2025-11-25 monthly https://www.oursmab.com/News/AbSet-A-Standardized-Data-Set-of-Antibody-Structures-for-Machine-Learning-Applications.html 0.5 2025-05-26 monthly https://www.oursmab.com/News/Nervous-system-regulatory-factor-LINGO1.html 0.5 2026-01-26 monthly https://www.oursmab.com/News/Regulatory-T-cell-activation-regulatory-receptor-LRRC32.html 0.5 2025-12-01 monthly https://www.oursmab.com/News/Target-of-treatment-for-acute-myeloid-leukemia-FLT3.html 0.5 2025-05-22 monthly https://www.oursmab.com/News/Coagulation-pathway-promoter-CD142.html 0.5 2026-01-26 monthly https://www.oursmab.com/News/The-tyrosine-protein-kinase-PDGFRA.html 0.5 2025-12-01 monthly https://www.oursmab.com/News/Myeloid-inhibitory-C-type-lectin-receptor-CLEC12A.html 0.5 2025-05-21 monthly https://www.oursmab.com/News/Emerging-immune-regulatory-target-BTN1A1.html 0.5 2026-01-20 monthly https://www.oursmab.com/News/The-Wnt-pathway-activates-the-receptor-family-FZD.html 0.5 2025-12-02 monthly https://www.oursmab.com/News/High-throughput-strategies-for-monoclonal-antibody-screening-advances-and-challenges.html 0.5 2025-05-20 monthly https://www.oursmab.com/News/Tumor-microenvironment-homeostasis-regulator-CLU.html 0.5 2026-01-19 monthly https://www.oursmab.com/News/Dendritic-spine-morphological-regulator-BAIAP2.html 0.5 2025-12-08 monthly https://www.oursmab.com/News/Tumor-immune-escape-promoting-factor-EpCAM.html 0.5 2025-05-19 monthly https://www.oursmab.com/News/Tumor-necrosis-factor-superfamily-receptor-TWEAKR.html 0.5 2026-01-19 monthly https://www.oursmab.com/News/The-vascular-adhesion-protein-VAP1.html 0.5 2025-12-09 monthly https://www.oursmab.com/News/CD37-as-a-Therapeutic-Target-for-Acute-Myeloid-Leukemia.html 0.5 2025-05-16 monthly https://www.oursmab.com/News/The-positive-regulator-of-complement-CFP.html 0.5 2026-01-13 monthly https://www.oursmab.com/News/P-selectin-glycoprotein-ligand-PSGL-1.html 0.5 2025-12-09 monthly https://www.oursmab.com/News/Alarm-cytokine-IL1A.html 0.5 2025-05-15 monthly https://www.oursmab.com/News/Carbonic-anhydrase-CA9.html 0.5 2026-01-13 monthly https://www.oursmab.com/News/Target-for-migraine-treatment-ADCYAP1.html 0.5 2025-12-15 monthly https://www.oursmab.com/News/Tumor-specific-marker-CD248.html 0.5 2025-05-15 monthly https://www.oursmab.com/News/Anti-Müllerian-Hormone-Signaling-Maintains-Circadian-Homeostasis-in-Zebrafish.html 0.5 2026-01-12 monthly https://www.oursmab.com/News/Neurotensin-receptor-SORT1.html 0.5 2025-12-15 monthly https://www.oursmab.com/News/Immune-checkpoint-protein-CD200.html 0.5 2025-05-14 monthly https://www.oursmab.com/News/Tyrosine-protein-kinase-receptor-AXL.html 0.5 2026-01-09 monthly https://www.oursmab.com/News/A-therapeutic-antibody-targeting-TM4SF4-with-anti-tumor-activity.html 0.5 2025-12-22 monthly https://www.oursmab.com/News/The-multiverse-of-CD46-and-oncologic-interactions.html 0.5 2025-05-13 monthly https://www.oursmab.com/News/Complement-Cascade-Initiator-C1s.html 0.5 2026-01-08 monthly https://www.oursmab.com/News/Calcitonin-gene-related-peptide-CGRP.html 0.5 2025-12-23 monthly https://www.oursmab.com/News/The-anaphylatoxin-receptor-C5AR1.html 0.5 2025-05-08 monthly https://www.oursmab.com/News/Tumor-immune-escape-therapy-target-HLAG.html 0.5 2026-01-07 monthly https://www.oursmab.com/News/A-key-regulator-of-the-vasculature-ADM.html 0.5 2025-12-23 monthly https://www.oursmab.com/News/Osteoclast-differentiation-and-activation-factor-RANKL.html 0.5 2025-05-07 monthly https://www.oursmab.com/News/Tumor-microenvironment-ammonia-drives-Treg-mediated-immunosuppression.html 0.5 2026-01-06 monthly https://www.oursmab.com/News/Wnt-signaling-coreceptor-LGR5.html 0.5 2026-01-05 monthly https://www.oursmab.com/News/CD30-is-a-therapeutic-target-for-lymphoma.html 0.5 2025-05-06 monthly https://www.oursmab.com/News/Cellular-cytoskeleton-regulatory-protein-VIM.html 0.5 2026-01-05 monthly https://www.oursmab.com/News/Mapping-affinity-and-allostery-in-human-IgG-antibody-Fc-region-Fcγ-receptor-interactions.html 0.5 2025-05-05 monthly https://www.oursmab.com/News/The-pleiotropic-cytokine-TGFB.html 0.5 2025-04-24 monthly https://www.oursmab.com/News/MSLN-is-the-target-of-solid-tumor-treatment.html 0.5 2025-04-22 monthly https://www.oursmab.com/News/Engineering-IgG-antibodies-for-intracellular-targeting-and-drug-delivery.html 0.5 2025-04-21 monthly https://www.oursmab.com/News/Bladder-Cancer-Treatment-Target-FGFR3.html 0.5 2025-04-16 monthly https://www.oursmab.com/News/The-cannabinoid-receptor-CNR1.html 0.5 2025-04-15 monthly https://www.oursmab.com/News/Inactivated-tyrosine-protein-kinase-PTK7.html 0.5 2025-04-14 monthly https://www.oursmab.com/News/A-novel-target-for-ADC-tumor-therapy-LRRC15.html 0.5 2025-04-09 monthly https://www.oursmab.com/News/T-cell-activation-inhibitor-VISTA.html 0.5 2025-04-08 monthly https://www.oursmab.com/News/Bispecific-antibody-heavy-and-light-chain-matching-design.html 0.5 2025-04-07 monthly https://www.oursmab.com/News/ADAM9-is-a-new-target-for-ADC-anticancer-therapy.html 0.5 2025-04-03 monthly https://www.oursmab.com/News/Allergic-trigger-IgE.html 0.5 2025-04-02 monthly https://www.oursmab.com/News/Antibody-diversity-and-specificity-and-new-insights-into-structure.html 0.5 2025-04-01 monthly https://www.oursmab.com/News/Angptl3-is-a-key-regulator-of-lipid-metabolism.html 0.5 2025-03-31 monthly https://www.oursmab.com/News/HIV-invades-the-coreceptor-CCR5.html 0.5 2025-03-28 monthly https://www.oursmab.com/News/B-lymphocyte-marker-CD19.html 0.5 2025-03-28 monthly https://www.oursmab.com/News/Development-of-bispecific-antibody-drug-conjugates-targeting-EpCAM-and-CLDN3.html 0.5 2025-03-27 monthly https://www.oursmab.com/News/The-chemokine-receptor-CCR4.html 0.5 2025-03-27 monthly https://www.oursmab.com/News/CCR8-a-promising-therapeutic-target-against-tumor-infiltrating-regulatory-T-cells.html 0.5 2025-03-25 monthly https://www.oursmab.com/News/The-folate-receptor-FOLR1.html 0.5 2025-03-24 monthly https://www.oursmab.com/News/Dont-eat-my-signaling-protein-CD47.html 0.5 2025-03-21 monthly https://www.oursmab.com/News/Macrophage-migration-inhibitor-MIF.html 0.5 2025-03-20 monthly https://www.oursmab.com/News/Advancements-in-Escherichia-coli-secretion-systems-for-enhanced-recombinant-protein-production.html 0.5 2025-03-18 monthly https://www.oursmab.com/News/Tumor-immune-regulator-CD70.html 0.5 2025-03-17 monthly https://www.oursmab.com/News/Multiple-myeloma-treatment-target-CD138.html 0.5 2025-03-14 monthly https://www.oursmab.com/News/Granulocyte-macrophage-stimulating-factor-CSF2.html 0.5 2025-03-13 monthly https://www.oursmab.com/News/The-chemokine-receptor-CXCR4.html 0.5 2025-03-12 monthly https://www.oursmab.com/News/Immune-Sentinel-TLR4.html 0.5 2025-03-11 monthly https://www.oursmab.com/News/YAbS-The-Antibody-Societys-antibody-therapeutics-database.html 0.5 2025-03-10 monthly https://www.oursmab.com/News/The-pleiotropic-cytokine-IL9.html 0.5 2025-03-07 monthly https://www.oursmab.com/News/Dual-inhibition-of-a-novel-bispecific-antibody-CDX-622.html 0.5 2025-03-05 monthly https://www.oursmab.com/News/The-target-of-tumor-immunotherapy-is-MUC1.html 0.5 2025-03-03 monthly https://www.oursmab.com/News/De-novo-designed-proteins-neutralize-lethal-snake-venom-toxins.html 0.5 2025-02-25 monthly https://www.oursmab.com/News/Receptor-ligand-interactions-for-optimized-endocytosis-in-targeted-therapies.html 0.5 2025-02-24 monthly https://www.oursmab.com/News/B-lymphocyte-antigen-CD20.html 0.5 2025-02-21 monthly https://www.oursmab.com/News/Decoding-the-Molecular-Basis-of-the-Specificity-of-an-Anti-sTn-Antibody.html 0.5 2025-02-20 monthly https://www.oursmab.com/News/Engineered-ipilimumab-variants-that-bind-human-and-mouse-CTLA-4.html 0.5 2025-02-18 monthly https://www.oursmab.com/News/The-glucose-regulatory-receptor-GIPR.html 0.5 2025-02-17 monthly https://www.oursmab.com/News/T-cell-immunomodulatory-factor-TIM3.html 0.5 2025-02-14 monthly https://www.oursmab.com/News/Therapeutic-target-of-inflammatory-bowel-disease-TL1A.html 0.5 2025-02-10 monthly https://www.oursmab.com/News/APRIL-is-a-therapeutic-target-for-IgA-nephropathy.html 0.5 2025-01-21 monthly https://www.oursmab.com/News/Mechanisms-treatment-and-management-of-tumors-of-the-digestive-system.html 0.5 2025-01-20 monthly https://www.oursmab.com/News/Insulin-like-growth-factor-1-receptor-IGF1R.html 0.5 2025-01-20 monthly https://www.oursmab.com/News/T-cell-specific-surface-glycoprotein-CD28.html 0.5 2025-01-17 monthly https://www.oursmab.com/News/The-immune-checkpoint-LAG-3.html 0.5 2025-01-16 monthly https://www.oursmab.com/News/CD123-is-a-therapeutic-target-for-blood-diseases.html 0.5 2025-01-14 monthly https://www.oursmab.com/News/Role-of-CCR2-CCL2-axis-in-cancer-immunity.html 0.5 2025-01-13 monthly https://www.oursmab.com/News/Nectin-4-is-a-novel-target-of-the-ADC-circuit.html 0.5 2025-01-10 monthly https://www.oursmab.com/News/The-cadherin-CDH6.html 0.5 2025-01-09 monthly https://www.oursmab.com/News/Key-differences-and-limitations-of-antibody-numbering-schemes.html 0.5 2025-01-07 monthly https://www.oursmab.com/News/Optimized-development-of-therapeutic-anti-oxMIF-antibodies-based-on-computer-and-in-vitro-tools.html 0.5 2025-01-06 monthly https://www.oursmab.com/News/Consideration-of-recombinant-expression-of-His-small-label-fusion-protein.html 0.5 2025-01-03 monthly https://www.oursmab.com/News/T-cell-costimulatory-molecule-OX40.html 0.5 2025-01-02 monthly https://www.oursmab.com/News/Trophoblast-cell-surface-antigen-TROP2.html 0.5 2024-12-31 monthly https://www.oursmab.com/News/Tissue-factor-pathway-inhibitor-TFPI.html 0.5 2024-12-30 monthly https://www.oursmab.com/News/Advancements-and-challenges-in-immunocytokines.html 0.5 2024-12-27 monthly https://www.oursmab.com/News/The-angiogenin-VEGFA.html 0.5 2024-12-25 monthly https://www.oursmab.com/News/The-immunosuppressive-molecule-B7H4.html 0.5 2024-12-23 monthly https://www.oursmab.com/News/Potent-AMA1-specific-human-monoclonal-antibody-against-Plasmodium-vivax.html 0.5 2024-12-20 monthly https://www.oursmab.com/News/claudin182-is-a-new-target-for-gastric-and-pancreatic-cancer.html 0.5 2024-12-19 monthly https://www.oursmab.com/News/Angiogenesis-regulatory-target-ANGPT2.html 0.5 2024-12-17 monthly https://www.oursmab.com/News/Autoimmune-disease-treatment-target-IL23A.html 0.5 2024-12-16 monthly https://www.oursmab.com/News/B-and-T-lymphocyte-attenuator-BTLA.html 0.5 2024-12-13 monthly https://www.oursmab.com/News/Immune-stimulation-of-the-cytokine-IL-15.html 0.5 2024-12-12 monthly https://www.oursmab.com/News/Immunoregulatory-factor-IL-22.html 0.5 2024-12-12 monthly https://www.oursmab.com/News/Strategies-to-boost-antibody-selectivity-in-oncology.html 0.5 2024-12-10 monthly https://www.oursmab.com/News/Factors-affecting-the-quality-of-therapeutic-proteins-in-Chinese-hamster-ovary-cell-culture.html 0.5 2024-12-09 monthly https://www.oursmab.com/News/GDF15-is-a-therapeutic-target-for-obesity.html 0.5 2024-12-05 monthly https://www.oursmab.com/News/Engineered-antibody-fusion-proteins-for-targeted-disease-therapy.html 0.5 2024-12-02 monthly https://www.oursmab.com/News/Immunomodulatory-adenosine-producer-CD73.html 0.5 2024-11-29 monthly https://www.oursmab.com/News/Prostate-specific-membrane-antigen-PSMA.html 0.5 2024-11-26 monthly https://www.oursmab.com/News/SSTR2-is-a-therapeutic-target-for-neuroendocrine-tumors.html 0.5 2024-11-25 monthly https://www.oursmab.com/News/Research-progress-of-fibroblast-activation-protein-FAP.html 0.5 2024-11-22 monthly https://www.oursmab.com/News/Efficient-generation-of-recombinant-anti-HER2-scFv-with-high-yield-and-purity.html 0.5 2024-11-19 monthly https://www.oursmab.com/News/Fusion-protein-linkers-property-design-and-functionality.html 0.5 2024-11-18 monthly https://www.oursmab.com/News/Overview-of-methods-used-in-the-study-of-protein-protein-interactions.html 0.5 2024-11-15 monthly https://www.oursmab.com/News/Overview-of-the-research-methods-of-protein-small-molecule-interactions.html 0.5 2024-11-14 monthly https://www.oursmab.com/News/STEAP1-is-a-therapeutic-target-for-prostate-cancer.html 0.5 2024-11-12 monthly https://www.oursmab.com/News/NPR1-is-a-therapeutic-target-for-heart-failure.html 0.5 2024-11-11 monthly https://www.oursmab.com/News/Recombinant-DsbA-protein-helps-develop-new-strategies-for-treating-drug-resistant-bacteria.html 0.5 2024-11-08 monthly https://www.oursmab.com/News/SpyTag-SpyCatcher-system-Protein-covalent-coupling-technology.html 0.5 2024-11-07 monthly https://www.oursmab.com/News/Pathogen-sensor-TLR2.html 0.5 2024-11-05 monthly https://www.oursmab.com/News/Skin-inflammation-treatment-target-IL36R.html 0.5 2024-11-04 monthly https://www.oursmab.com/News/Alzheimer-disease-therapeutic-target-TREM2.html 0.5 2024-11-01 monthly https://www.oursmab.com/News/Introduction-to-proximity-marking-technology.html 0.5 2024-10-30 monthly https://www.oursmab.com/News/Proximity-labeling-in-mammalian-cells-with-TurboID-and-split-TurboID.html 0.5 2024-10-29 monthly https://www.oursmab.com/News/Small-cell-lung-cancer-treatment-target-DLL3.html 0.5 2024-10-28 monthly https://www.oursmab.com/News/Interleukin-27.html 0.5 2024-10-27 monthly https://www.oursmab.com/News/T-cells-costimulate-the-immune-checkpoint-molecule-4-1BB.html 0.5 2024-10-25 monthly https://www.oursmab.com/News/Epidermal-growth-factor-receptor-EGFR.html 0.5 2024-10-24 monthly https://www.oursmab.com/News/Treatment-of-obesity-and-metabolic-diseases-target-GLP1R.html 0.5 2024-10-22 monthly https://www.oursmab.com/News/How-to-isolate-channel-forming-membrane-proteins-using-the-Ecoli-expression-system.html 0.5 2024-10-21 monthly https://www.oursmab.com/News/The-immune-checkpoint-molecule-B7H3.html 0.5 2024-10-18 monthly https://www.oursmab.com/News/Comparative-study-of-the-exploitability-of-full-length-antibody-fragment-and-bispecific-formats.html 0.5 2024-10-17 monthly https://www.oursmab.com/News/A-single-chain-fab-derived-drug-conjugate-for-HER2-specific-delivery.html 0.5 2024-10-16 monthly https://www.oursmab.com/News/The-inflammatory-itch-cytokine-IL-31.html 0.5 2024-10-15 monthly https://www.oursmab.com/News/Recombinant-antibodies-antibody-sequencing-and-artificial-intelligence-help-antibody-design.html 0.5 2024-10-14 monthly https://www.oursmab.com/News/Hepatocyte-growth-factor-receptor-c-MET.html 0.5 2024-10-11 monthly https://www.oursmab.com/News/The-role-of-glycosylation-in-cancer-and-clinical-therapy.html 0.5 2024-10-09 monthly https://www.oursmab.com/News/The-target-of-angiogenesis-regulation-is-DLL4.html 0.5 2024-10-08 monthly https://www.oursmab.com/News/Dual-blockade-immunotherapy-targeting-PD-1-PD-L1-and-CTLA-4-in-lung-cancer.html 0.5 2024-10-08 monthly https://www.oursmab.com/News/Autoimmune-cancer-testicular-antigen-NY-ESO-1.html 0.5 2024-09-26 monthly https://www.oursmab.com/News/The-hepatocellular-carcinoma-marker-GPC3.html 0.5 2024-09-24 monthly https://www.oursmab.com/News/The-proinflammatory-cytokine-IL-18.html 0.5 2024-09-20 monthly https://www.oursmab.com/News/The-unique-cadherin-CDH17.html 0.5 2024-09-20 monthly https://www.oursmab.com/News/Improving-Protein-Expression-Stability-and-Function-with-ProteinMPNN.html 0.5 2024-09-18 monthly https://www.oursmab.com/News/The-Effects-of-Codon-Usage-on-Protein-Structure-and-Folding.html 0.5 2024-09-18 monthly https://www.oursmab.com/News/Developability-considerations-for-bispecific-and-multispecific-antibodies.html 0.5 2024-09-12 monthly https://www.oursmab.com/News/The-cell-adhesion-molecule-ICAM1.html 0.5 2024-09-11 monthly https://www.oursmab.com/News/The-inhibitory-receptor-TIGIT.html 0.5 2024-09-10 monthly https://www.oursmab.com/News/Suitable-conditions-were-selected-for-eukaryotic-protein-expression.html 0.5 2024-09-09 monthly https://www.oursmab.com/News/Immune-stimulation-of-the-cytokine-IL-21.html 0.5 2024-09-05 monthly https://www.oursmab.com/News/Novel-immunotherapeutics-against-LGR5-to-target-multiple-cancer-types.html 0.5 2024-09-04 monthly https://www.oursmab.com/News/Neonatal-Fc-receptor-FcRn.html 0.5 2024-09-03 monthly https://www.oursmab.com/News/B-cell-activating-factor-BAFF.html 0.5 2024-09-02 monthly https://www.oursmab.com/News/Human-epidermal-growth-factor-receptor-HER2.html 0.5 2024-08-30 monthly https://www.oursmab.com/News/Receptor-tyrosine-kinase-like-orphan-receptor-ROR1.html 0.5 2024-08-29 monthly https://www.oursmab.com/News/The-target-of-Fibroblast-growth-factor-receptor-FGFR1.html 0.5 2024-08-28 monthly https://www.oursmab.com/News/The-IL-7-fusion-protein-F8-scDb-IL7-up-regulates-TCF1-and-promotes-PD-1-blockade.html 0.5 2024-08-27 monthly https://www.oursmab.com/News/A-two-component-T-cell-activation-therapy-MATCH.html 0.5 2024-08-26 monthly https://www.oursmab.com/News/Fc-enhanced-CTLA-4-antibody-enhances-therapeutic-efficacy.html 0.5 2024-08-23 monthly https://www.oursmab.com/News/B-cell-maturation-antigen-BCMA.html 0.5 2024-08-20 monthly https://www.oursmab.com/News/Inducible-T-cell-costimulator-ICOS.html 0.5 2024-08-19 monthly https://www.oursmab.com/News/Immune-checkpoint-suppressor-molecule-Siglec15.html 0.5 2024-08-16 monthly https://www.oursmab.com/News/Accurate-prediction-of-protein-function-using-statistics-informed-graph-networks.html 0.5 2024-08-14 monthly https://www.oursmab.com/News/Single-domain-antibodies-as-therapeutics-for-solid-tumor-treatment.html 0.5 2024-08-13 monthly https://www.oursmab.com/News/Lipid-control-protein-PCSK9.html 0.5 2024-08-12 monthly https://www.oursmab.com/News/Human-epidermal-growth-factor-receptor-HER3.html 0.5 2024-08-09 monthly https://www.oursmab.com/News/rhIL-7-hyFc-improves-the-efficacy-of-CAR-T-cells-in-the-treatment-of-solid-tumors.html 0.5 2024-08-08 monthly https://www.oursmab.com/News/Thymic-stromal-lymphopoietin-TSLP.html 0.5 2024-08-08 monthly https://www.oursmab.com/News/ANV419-has-a-strong-ability-to-stimulate-CD8-T-cells-and-natural-killer-cells.html 0.5 2024-08-07 monthly https://www.oursmab.com/News/Problems-and-solutions-for-recombinant-protein-expression-in-prokaryotic-Escherichia-coli.html 0.5 2024-08-07 monthly https://www.oursmab.com/News/Proinflammatory-cytokine-IL-11.html 0.5 2024-08-06 monthly https://www.oursmab.com/News/Clinical-validation-of-Fc-mutations-can-adjust-the-high-viscosity-of-IgG1-antibodies.html 0.5 2024-08-06 monthly https://www.oursmab.com/News/The-alarm-cytokine-IL-33.html 0.5 2024-08-05 monthly https://www.oursmab.com/News/Integrin-alpha-CD51.html 0.5 2024-07-26 monthly https://www.oursmab.com/News/Stimulate-receptor-molecules-CD40.html 0.5 2024-07-24 monthly https://www.oursmab.com/News/Interleukin-IL13.html 0.5 2024-07-22 monthly https://www.oursmab.com/News/The-challenges-and-breakthroughs-in-the-development-of-diagnostic-monoclonal-antibodies.html 0.5 2024-07-18 monthly https://www.oursmab.com/News/Engineering-a-tumor-selective-prodrug-T-cell-engager-bispecific-antibody-for-safer-immunotherapy.html 0.5 2024-07-16 monthly https://www.oursmab.com/News/The-introduction-of-protein-tag.html 0.5 2024-07-12 monthly https://www.oursmab.com/News/The-binding-mechanism-of-an-anti-multiple-myeloma-antibody-to-the-human-GPRC5D-homodimer.html 0.5 2024-07-05 monthly https://www.oursmab.com/News/Siglec-6-as-a-therapeutic-target-for-cell-migration-and-adhesion-in-chronic-lymphocytic-leukemia.html 0.5 2024-07-04 monthly https://www.oursmab.com/News/Central-nervous-system-specific-proteins-S100β.html 0.5 2024-07-03 monthly https://www.oursmab.com/News/A-new-marker-for-ovarian-cancer-detection-HE4.html 0.5 2024-07-02 monthly https://www.oursmab.com/News/Ovarian-cancer-marker-CA125.html 0.5 2024-06-27 monthly https://www.oursmab.com/News/hepatocellular-carcinoma-biomarker-AFP.html 0.5 2024-06-25 monthly https://www.oursmab.com/News/Prostate-cancer-biomarker-PSA.html 0.5 2024-06-21 monthly https://www.oursmab.com/News/The-sepsis-biomarker-PCT.html 0.5 2024-06-20 monthly https://www.oursmab.com/News/Sensitive-inflammatory-markers-SAA.html 0.5 2024-06-19 monthly https://www.oursmab.com/News/Broad-spectrum-tumor-markers-CEA.html 0.5 2024-06-18 monthly https://www.oursmab.com/News/The-inflammatory-marker-CRP.html 0.5 2024-06-15 monthly https://www.oursmab.com/News/The-heart-failure-marker-ST2.html 0.5 2024-06-14 monthly https://www.oursmab.com/News/Development-and-characterization-of-pharmacokinetics-assay-for-the-bispecific-antibody-cibisatamab.html 0.5 2024-06-13 monthly https://www.oursmab.com/News/Structural-basis-for-selectivity-and-antagonism-in-extracellular-GPCR-nanobodies.html 0.5 2024-06-12 monthly https://www.oursmab.com/News/Heart-failure-biomarkers-NT-ProBNP-and-BNP.html 0.5 2024-06-11 monthly https://www.oursmab.com/News/Anti-DCIR-antibody-inhibits-ITAM-mediated-inflammatory-signaling-and-promotes-immune-resolution.html 0.5 2024-06-07 monthly https://www.oursmab.com/News/AggreProt-a-web-server-for-predicting-and-engineering-aggregation-pron-eregions-in-proteins.html 0.5 2024-06-06 monthly https://www.oursmab.com/News/The-key-factors-in-IgG1-secretion-are-CH-CL-pairing-and-VL-domain-integrity.html 0.5 2024-06-05 monthly https://www.oursmab.com/News/Two-sided-interferon-IFNγ.html 0.5 2024-06-03 monthly https://www.oursmab.com/News/Cancer-therapy-with-antibodies.html 0.5 2024-05-24 monthly https://www.oursmab.com/News/Applying-pBsAbs-to-immunotherapy-through-a-biological-conjugation-strategy.html 0.5 2024-05-23 monthly https://www.oursmab.com/News/The-stem-cell-factor-receptor-CD117.html 0.5 2024-05-22 monthly https://www.oursmab.com/News/Interleukin-7-receptor-alpha-subunit-CD127.html 0.5 2024-05-21 monthly https://www.oursmab.com/News/Antitumor-immunity-by-anti-PD-L1-IL-15-immune-cytokines.html 0.5 2024-05-17 monthly https://www.oursmab.com/News/CD74-supports-accumulation-and-function-of-regulatory-T-cells-in-tumors.html 0.5 2024-05-16 monthly https://www.oursmab.com/News/CD74-is-a-cell-surface-receptor-for-the-macrophage-factor-MIF.html 0.5 2024-05-15 monthly https://www.oursmab.com/News/Macrophage-colony-stimulating-factor-1-receptor-CD115.html 0.5 2024-05-14 monthly https://www.oursmab.com/News/The-vascular-disease-marker-CD105.html 0.5 2024-05-11 monthly https://www.oursmab.com/News/Introduction-to-engineering-design-of-recombinant-antibody.html 0.5 2024-05-11 monthly https://www.oursmab.com/News/Anti-tumor-efficacy-of-Trop2-targeting-antibody-drug-conjugate.html 0.5 2024-05-10 monthly https://www.oursmab.com/News/CovEpiAb-A-coronavirus-immune-epitope-and-antibody-database.html 0.5 2024-05-09 monthly https://www.oursmab.com/News/Introduction-to-antibody-structure-subtype.html 0.5 2024-05-08 monthly https://www.oursmab.com/News/CD79-is-a-therapeutic-target-for-B-celllymphoma.html 0.5 2024-05-07 monthly https://www.oursmab.com/News/The-adhesion-molecule-CD62.html 0.5 2024-04-29 monthly https://www.oursmab.com/News/The-transferrin-receptor-CD71.html 0.5 2024-04-29 monthly https://www.oursmab.com/News/Structure-and-function-of-therapeutic-antibodies-approved-by-the-FDA-in-2023.html 0.5 2024-04-28 monthly https://www.oursmab.com/News/Natural-killer-cells-typing-marker-CD56.html 0.5 2024-04-26 monthly https://www.oursmab.com/News/Pathological-study-of-anti-human-LILRB4-antibody-in-a-mouse-model-of-Alzheimers-disease.html 0.5 2024-04-26 monthly https://www.oursmab.com/News/Blood-cancer-therapeutic-target-CD45.html 0.5 2024-04-25 monthly https://www.oursmab.com/News/The-membrane-attack-complex-inhibitor-CD59.html 0.5 2024-04-25 monthly https://www.oursmab.com/News/The-complement-inhibitor-CD55.html 0.5 2024-04-24 monthly https://www.oursmab.com/News/Therapeutic-target-for-multiple-myeloma-CD38.html 0.5 2024-04-24 monthly https://www.oursmab.com/News/Detection-of-small-molecule-ethylpyrimol-residues-in-agricultural-products-and-environment.html 0.5 2024-04-24 monthly https://www.oursmab.com/News/Functional-IgG-like-stability-and-pharmacological-studies-of-tetravalent-bispecific-antibodies.html 0.5 2024-04-23 monthly https://www.oursmab.com/News/The-scavenger-receptor-CD36.html 0.5 2024-04-18 monthly https://www.oursmab.com/News/CD33-is-a-potential-therapeutic-target.html 0.5 2024-04-16 monthly https://www.oursmab.com/News/The-complement-receptor-CD35.html 0.5 2024-04-15 monthly https://www.oursmab.com/News/Anaphylaxis-regulatory-receptor-CD23.html 0.5 2024-03-21 monthly https://www.oursmab.com/News/Potential-tumor-therapeutic-target-CD25.html 0.5 2024-03-21 monthly https://www.oursmab.com/News/ADCC-effect-factor-CD16.html 0.5 2024-03-20 monthly https://www.oursmab.com/News/CD14-The-pattern-recognition-receptor-for-LPS.html 0.5 2024-03-13 monthly https://www.oursmab.com/News/CD19-CD20-antibody-fusion-IL15-protein-dual-targeted-therapy-for-B-cell-malignancies.html 0.5 2024-03-13 monthly https://www.oursmab.com/News/Antibody-engineering-series-bispecific-antibody.html 0.5 2024-03-13 monthly https://www.oursmab.com/News/Polyhedral-aminopeptidase-CD13.html 0.5 2024-03-05 monthly https://www.oursmab.com/News/Proinflammatory-cytokine-IL17.html 0.5 2024-03-04 monthly https://www.oursmab.com/News/Tumor-microenvironment-regulator-IL8.html 0.5 2024-02-28 monthly https://www.oursmab.com/News/The-integrin-family-molecule-CD11.html 0.5 2024-02-27 monthly https://www.oursmab.com/News/the-target-of-cellular-immunotherapy-CD7.html 0.5 2024-02-24 monthly https://www.oursmab.com/News/eosinophilic-inflammatory-factor-IL5.html 0.5 2024-02-23 monthly https://www.oursmab.com/News/Allergic-response-regulator-IL4.html 0.5 2024-02-17 monthly https://www.oursmab.com/News/Immunosuppressive-therapy-target-CD2.html 0.5 2024-02-17 monthly https://www.oursmab.com/News/Fc-engineering-modification-for-regulating-antibody-function.html 0.5 2024-01-23 monthly https://www.oursmab.com/News/The-lipid-antigen-presenting-molecule-CD1a.html 0.5 2024-01-17 monthly https://www.oursmab.com/News/Inflammatory-cytokine-IL1β.html 0.5 2024-01-17 monthly https://www.oursmab.com/News/Characterization-of-neutralizing-antibodies-of-broad-spectrum-glutenopeptideHLA-DQ25complex.html 0.5 2024-01-04 monthly https://www.oursmab.com/News/Key-molecules-on-the-surface-of-cytotoxic-T-cells--TNFa.html 0.5 2023-12-27 monthly https://www.oursmab.com/News/Targeted-MMP9-therapy-synergistically-improves-anti-PD1-efficacy.html 0.5 2023-12-20 monthly https://www.oursmab.com/News/Comparison-of-mapping-techniques-of-different-antibody-epitopes.html 0.5 2023-12-11 monthly https://www.oursmab.com/News/Cytotoxic-T-cell-surface-key-molecule--CD4.html 0.5 2023-12-11 monthly https://www.oursmab.com/News/Cytotoxic-T-cell-surface-key-molecule--CD8.html 0.5 2023-12-02 monthly https://www.oursmab.com/News/SND1-potential-prostate-cancer-target.html 0.5 2023-12-01 monthly https://www.oursmab.com/News/T-lymphocyte-surface-key-molecule-CD3.html 0.5 2023-11-15 monthly https://www.oursmab.com/News/polygenic-proinflammatory-cytokine-IL6.html 0.5 2023-11-09 monthly https://www.oursmab.com/News/The-advent-of-the-era-of-antibody-coupled-drug-ADC.html 0.5 2023-06-21 monthly https://www.oursmab.com/News/Literature-share-antibody-sequences-defined-a-new-target-for-osteosarcoma-CAR-T-therapy.html 0.5 2023-06-13 monthly https://www.oursmab.com/News/multiplexed-selectivity-screening-of-anti-GPCR-antibodies.html 0.5 2023-05-12 monthly https://www.oursmab.com/News/Pyroptosis-the-GSDM-family.html 0.5 2023-03-27 monthly https://www.oursmab.com/News/Known-antibody-sequence-development-again.html 0.5 2023-03-15 monthly https://www.oursmab.com/News/Transport-protein-superfamily-SLC.html 0.5 2023-03-08 monthly https://www.oursmab.com/News/Specific-transcriptional-coactivator-YAP1.html 0.5 2023-03-01 monthly https://www.oursmab.com/News/Protein-family-FGF.html 0.5 2023-02-13 monthly https://www.oursmab.com/News/FGF11-potential-obesity-target.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF7-Regulation-of-drug-tolerance.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF16-a-regulatory-target-for-cardiomyocytes.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF6-regulating-muscle-regeneration-Cardiac-repair.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF14-a-new-potential-target-for-brain-diseases.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF5-a-key-regulator-of-hair-growth.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF13-A-thriving-regulatory-molecule.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF22-Neurons-to-reshape-regulator.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF4-a-potential-target-for-lowering-glucose.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF21-metabolic-messenger.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF12-a-multifaceted-regulator.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF3-Regulation-of-embryonic-ear-development.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF2-A-myriad-factor.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF20-more-research-attention.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF10-a-repair-agent-for-lung-heart-injury.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF19-Clinical-value-to-be-exploited.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF9-regulator-of-gonadal-differentiation.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF1-an-antidiabetic-potential-drug-target.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF18-a-therapeutic-target-for-osteoarthritis.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF8-a-potential-target-for-oral-diseases.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF17-aging-memory-defect-potential-target.html 0.5 2023-02-02 monthly https://www.oursmab.com/News/FGF23-a-family-pioneer-in-targeted-therapy.html 0.5 2022-02-02 monthly